Www.vin.bg.ac.rs



Dr. Romana Masnikosa

Vinča Institute of Nuclear Sciences

P. O. Box 522, 11000 Belgrade

romana@vin.bg.ac.rs

PRINCIPAL INVESTIGATOR

|AREAS OF EXPERTISE |

|lipid biochemistry |medicinal inorganic chemistry |

|biophysical chemistry of macromolecules | |

|protein glycosylation | |

| | |

|EDUCATION |

Ph.D. in Biochemistry, Faculty of Chemistry, University of Belgrade

Professional Training:

• 3 months in Lipidomics Unit, Institute of Physiological Chemistry, Medical University of Johannes Gutenberg University of Mainz, Mainz, Germany (2019)

• 4 months at Laboratory for Biomolecular Interactions and Spectroscopy, Ruđer Bošković Institute, Zagreb, Croatia in period 2015-2017.

• Guest scientist at Glycoscience Laboratory-GENOS, Zagreb, Croatia (february 2015.)

• Guest scientist at Center of Proteomics and Mass Spectrometry Ruđer Bošković Institute, Zagreb, Croatia (march 2015.)

|PROFESIONAL EXPERIENCE |

• Institute of Nuclear Energy “Vinča”, National Institute of the Republic of Serbia, University of Belgrade, Serbia

principal investigator (october 2020-)

• Institute of Nuclear Energy “Vinča”, National Institute of the Republic of Serbia, University of Belgrade, Serbia

senior research associate (april 2014-october 2020)

• Institute for the Application of Nuclear Energy, University of Belgrade, Zemun-Belgrade, Serbia

senior research associate (december 2012-april 2014)

• Institute for the Application of Nuclear Energy, Zemun-Belgrade, Serbia

research associate (october 2007-december 2012)

• Institute for the Application of Nuclear Energy, Zemun-Belgrade, Serbia

research assistant (december 2000-october 2007)

• Institute for the Application of Nuclear Energy, Zemun-Belgrade, Serbia

research trainee (january 1997-december 2000)

|HONORS |

|SUPERVISION OF GRADUATE STUDENTS |

• Mentor of PhD thesis of Dragana Robajac, which was defended 2016. at Faculty of Chemistry, University of Belgrade, Serbia.

• Mentor of 2 diploma theses defended at Faculty of Chemistry, University of Belgrade, Serbia.

|INVITED TALKS |

• ,,Metallomics and mass spectrometry for drug development: employing ICP-MS and MALDI TOF MS for assessing protein-drug interactionsˮ. 9. Conference of Serbian Biochemical Society: Diversity in Biochemistry, Faculty of Chemistry, Belgrade, Serbia (2019).

• Third regional round table: Refractory, Process Industry, Nanotechnology and Nanomedicine, with international participation, ROSOV PIN june 2017, Avala-Belgrade, Serbia

|COLLABORATIVE PROJECTS |

• dr Laura Bindila, Head of Lipidomics Unit, Institute of Physiological Chemistry, Medical University of Johannes Gutenberg University of Mainz, Mainz, Germany

• dr Mario Cindrić, Center of Proteomics and Mass Spectrometry Ruđer Bošković Institute, Zagreb, Croatia

• dr Ivo Crnolatac, Laboratory for Biomolecular Interactions and Spectroscopy, Ruđer Bošković Institute, Zagreb, Croatia

• dr Valerie Vanhooren, Department of Molecular Biomedical Research, University of Ghent, Ghent, Belgija

|NUMBER OF PUBLICATIONS & CITATIONS |

• 42 publications in peer reviewed journals.

• Citations without self-citations: 250

|LIST OF SELECTED PAPERS |

-D Robajac, R Masnikosa, V Vanhooren, C Libert, Ž Miković, O Nedić, The N-glycan profile of placental membrane glycoproteins alters during gestation and aging. Mech Aging Dev (2014), 138, 1-9. M21, IF 3.51.

-M Nišavić, R Masnikosa, A Butorac, K Perica, A Rilak, L Korićanac, A Hozić, M Petković, M Cindrić, Elucidation of the binding sites of two novel Ru (II) complexes on bovine serum albumin. J Inorg Biochem (2016), 159, 89-95. M21, IF 3.44.

-Z Cvetković, M Milošević, B Cvetković, R Masnikosa, A Arsić, S Petrović, V Vučić, Plasma phospholipid changes are associated with response to chemotherapy in non-Hodgkin lymphoma patients. Leukemia Res (2017), 54, 39-46. M22, IF 2.61.

-M Nišavić, M Stoiljković, I Crnolatac, M Milošević, A Rilak, R Masnikosa, Highly water-soluble Ru (II) terpyridine coordination compounds form stable adducts with blood-borne metal transporting proteins. Arab J Chem (2018), 11, 291-304. M21, IF 4.553.

-S Radisavljević, I Bratsos, A Scheurer, J Korzekwa, R Masnikosa, A Tot, N Gligorijević, S Radulović, A Rilak, New gold pincer-type complexes: Synthesis, characterization, DNA binding studies and cytotoxicity. Dalton Trans (2018), 47, 13696-13712. M21, IF 4.10.

-MM Milutinović, PP Čanović, D Stevanović, R Masnikosa, M Vraneš, A Tot, MM Zarić, B Simović Marković, M Misirkić Marjanović, Lj Vučićević, M Savić, V Jakovljević, V Trajković, V Volarević, T Kanjevac, A Rilak Simović, Newly synthesized heteronuclear ruthenium(II)/ferrocene complexes suppress the growth of mammary carcinoma in 4T1-treated BALB/c mice by promoting activation of antitumor imunity. Organometallics (2018), 37, 4250-4266. M21, IF 4.10.

-A Rilak-Simović, R Masnikosa, I Bratsos, E Alessio, Chemistry and reactivity of ruthenium(II) complexes: DNA/protein binding mode and anticancer activity are related to the complex structure. Coord Chem Rev (2019), 398, 13696-13712. M21a, IF 14.499.

-D Robajac, M Nemčovič, M Križáková, L Belicka Kluková, P Baráth, J Katrlík, R Masnikosa, O Nedić, Glycoanalysis of the placental membrane glycoproteins throughout placental development. Mech Ageing Dev (2019), 183, # 111151. M21, IF 3.75.

- D Robajac, M Križáková, R Masnikosa, G Miljuš, M Šunderić, O Nedić, J Katrlík, Sensitive glycoprofiling of insulin-like growth factor receptors isolated from colon tissue of patients with colorectal carcinoma using lectin-based protein microarray, Int J Biol Macromol (2020), 144, 932-937, M21a, IF 5.162.

- R Masnikosa, MM Milutinović, I Crnolatac, A Tot, S Veličković, Ž Bojić-Trbojević, A Rilak-Simović, Anti-adhesive action of novel ruthenium(II) chlorophenyl terpyridine complexes with a high affinity for double-stranded DNA: in vitro and in silico, J Inorg Biochem (2020), 208, # 11090, M21, IF 3.212.

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download